The Board of Directors approved an increase in the regular quarterly cash dividend to $0.315 per share, representing a 1.6% rise over the prior payout. The dividend is payable on January 5, 2027, to shareholders of record as of December 17, 2026. Utah Medical Products develops, manufactures and markets specialty medical devices for women and babies.
